http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E5%8F%91%E7%83%AD-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%82%8C%E7%97%9B 2026-05-26T22:29:34Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E5%8F%91%E7%83%AD-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%82%8C%E7%97%9B&diff=1593974&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E5%8F%91%E7%83%AD-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%82%8C%E7%97%9B&diff=1593975&oldid=prev 2024-07-06T12:24:01Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 12:24的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8" >第8行：</td> <td colspan="2" class="diff-lineno">第8行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===唑来膦酸治疗风湿病并发骨代谢异常急性期反应及处理对策（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===唑来膦酸治疗风湿病并发骨代谢异常急性期反应及处理对策（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[发热]]为最常见的急性期反应,28例(29.5％)出现[[发热]],26例为中低度[[发热]],2例高热;其次为头痛(22.1％)、[[肌痛]](15.8％)和关节痛(12.6％);2l例(22.1％)患者给予药物干预.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>[[发热]]为最常见的急性期反应,28例(29.5％)出现[[发热]],26例为中低度[[发热]],2例高热;其次为头痛(22.1％)、[[肌痛]](15.8％)和关节痛(12.6％);2l例(22.1％)患者给予药物干预.</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===NLRP12自身炎症性疾病2例及文献复习（中华医学会文献）===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[发热]]时伴荨麻疹样皮疹、关节痛和[[肌痛]]，热退后上述症状消失。</ins></div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E5%8F%91%E7%83%AD-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%82%8C%E7%97%9B&diff=798283&oldid=prev 2021-11-23T04:05:05Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月23日 (二) 04:05的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E5%8F%91%E7%83%AD-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%82%8C%E7%97%9B&diff=798279&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[发热]]，关系：[[临床表现]] ，尾实体：[[肌痛]]<br /> <br /> 实体ID:''8733712''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===唑来膦酸治疗风湿病并发骨代谢异常急性期反应及处理对策（中华医学会文献）===<br /> [[发热]]为最常见的急性期反应,28例(29.5％)出现[[发热]],26例为中低度[[发热]],2例高热;其次为头痛(22.1％)、[[肌痛]](15.8％)和关节痛(12.6％);2l例(22.1％)患者给予药物干预.</div>

Admin